肝脏影像报告和数据系统(LI-RADS)v2017在预测儿童患者恶性肝脏病变中的诊断性能:初步研究
本研究回顾性纳入151个儿童肝脏病变,最终41个病变(3个HCC、8个非HCC恶性肿瘤、30个良性病变)由两名阅片者独立应用LI-RADS v2017评估。LI-RADS「明确HCC」诊断HCC的敏感度高(两名阅片者均为100%),但阳性预测值仅33%和75%;「明确或可能恶性」诊断任何类型肝脏恶性肿瘤的敏感度为100%和90%,阴性预测值为100%和96%。
要点
- LI-RADS「明确HCC」在儿童中诊断HCC敏感度为100%,但阳性预测值仅33%和75%(两名阅片者)。
- LI-RADS「明确或可能恶性」诊断任何肝脏恶性肿瘤的敏感度为100%和90%,阴性预测值为100%和96%。
- LI-RADS总体分类的观察者间一致性为中等(加权κ=0.62,95%CI 0.38-0.86)。
核心结论
- LI-RADS v2017诊断儿童HCC的阳性预测值受儿童HCC低发病率限制,但「明确或可能恶性」分类对任何类型肝脏恶性肿瘤具有高敏感度和阴性预测值,可能通过选择患者进行组织采样来指导临床管理。
研究设计与样本
- 回顾性、经机构审查委员会批准的研究,回顾一家三级儿童医院10年期间所有腹部动态增强影像,获得年龄<18岁患者的151个肝脏病变,排除活动性肝外恶性肿瘤或参考标准不充分的病例,最终41例患者41个病变纳入分析,由两名阅片者独立应用LI-RADS标准评估,以病理和影像随访为参考标准。
诊断标准与关键数值
- LI-RADS「明确HCC」预测HCC:阅片者1敏感度100%(95%CI 31-100%)、特异度84%(95%CI 68-93%)、阳性预测值33%(95%CI 9-69%);阅片者2敏感度100%(95%CI 31-100%)、特异度97%(95%CI 85-100%)、阳性预测值75%(95%CI 22-99%)。
- LI-RADS「明确或可能恶性」预测任何类型肝脏恶性肿瘤:阅片者1敏感度100%(95%CI 74-100%)、阴性预测值100%(95%CI 81-100%);阅片者2敏感度90%(95%CI 61-100%)、阴性预测值96%(95%CI 83-99%)。
- LI-RADS总体分类观察者间一致性:加权κ=0.62(95%CI 0.38-0.86)。
临床应用与阅片要点
- 在儿童肝脏病变评估中,LI-RADS「明确或可能恶性」分类对排除任何类型肝脏恶性肿瘤有较高阴性预测值(阅片者1为100%,阅片者2为96%)。
- LI-RADS「明确HCC」在儿童中阳性预测值有限(阅片者1为33%,阅片者2为75%),作者认为可能通过选择患者进行组织采样来指导临床管理。
局限性
- 本研究为回顾性研究。
- LI-RADS v2017诊断儿童HCC的阳性预测值受儿童HCC低发病率限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Liver Imaging Reporting and Data System (LI-RADS) has standardized the evaluation of hepatic lesions in adults at risk of developing hepatocellular carcinoma (HCC). There is no accepted imaging algorithm for diagnosing HCC in the pediatric population.
OBJECTIVE: The aim of our study was to evaluate the diagnostic accuracy and inter-rater reliability of LI-RADS version 2017 (v2017) for diagnosing HCC in a pediatric cohort.
MATERIALS AND METHODS: This retrospective, Institutional Review Board-approved study involved review of all abdominal dynamic contrast-enhanced imaging at a tertiary children's hospital during a 10-year period, yielding 151 liver lesions in patients <18 years. Cases with active extrahepatic malignancy or an inadequate reference standard were excluded. Two readers independently evaluated all included hepatic lesions using LI-RADS criteria. Pathology and imaging follow-up were used as reference standards.
RESULTS: A total of 41 lesions in 41 patients met criteria for evaluation (3 HCCs, 8 non-HCC malignancies, 30 benign lesions). A LI-RADS designation of definite HCC had high sensitivity (Reader 1/Reader 2: 100%, 95% confidence interval [CI] 31-100%) and high specificity (Reader 1: 84%, 95% CI: 68-93%; Reader 2: 97%, 95% CI: 85-100%) for predicting HCC. However, positive predictive value was only 33% (95% CI: 9-69%) and 75% (95% CI: 22-99%) for Reader 1 and Reader 2, respectively. For predicting any type of hepatic malignancy, a LI-RADS designation of definitely or likely malignant (i.e. not necessarily HCC) had a sensitivity of 100% (95% CI: 74-100%) and 90% (95% CI: 61-100%) for Reader 1 and Reader 2, respectively, and a negative predictive value (NPV) of 100% (95% CI: 81-100%) and 96% (95% CI: 83-99%) for Reader 1 and Reader 2, respectively. Interobserver agreement was substantial for the overall LI-RADS category (weighted κ=0.62; 95% CI: 0.38-0.86).
CONCLUSION: The positive predictive value of LI-RADS v2017 for diagnosing HCC was limited by the low frequency of HCC among pediatric patients. However, a LI-RADS designation of definitely or likely malignant had high sensitivity and NPV for any type of hepatic malignancy and may serve to direct clinical management by selecting patients for tissue sampling.
引用
- Ludwig DR, Romberg EK, Fraum TJ, et al. Diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS) v2017 in predicting malignant liver lesions in pediatric patients: a preliminary study. Pediatr Radiol. 2019. PMID: 31069473. doi:10.1007/s00247-019-04358-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。